We are advancing a pipeline of novel therapeutics for autism, epilepsies, and other CNS disorders.
At IAMA Therapeutics, we are driven by the ambition to transform the treatment of neurological and psychiatric disorders through innovation in chloride transporter modulation.
Discover how IAMA is working to restore neuronal balance and improve the lives of patients with neurological and psychiatric disorders.
science
Pushing the boundaries of neuroscience drug discovery
We couple emerging advances in neuroscience drug discovery and precision medicine to develop our pipeline of small molecules for CNS disorders. Our approach aims at selectively inhibiting cation-chloride cotransporters, which are relevant to rescue atypical brain activity in neurological conditions.
team
Working at IAMA therapeutics
We are a team of scientists, researchers, and biotech industry experts who value excellence, innovation, integrity, equality, respect for diversity, and the sustainability of our future generations.
